Cai Minqi, Zheng Qian, Chen Yiqiang, Liu Siyuan, Zhu Huimin, Bai Bing
Department of Laboratory Medicine, Nanjing Drum Tower Hospital Clinical College of Jiangsu University, Nanjing, Jiangsu, China.
Health Management Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Front Mol Neurosci. 2024 Apr 4;17:1379726. doi: 10.3389/fnmol.2024.1379726. eCollection 2024.
Netrin-1 was initially discovered as a neuronal growth cue for axonal guidance, and its functions have later been identified in inflammation, tumorigenesis, neurodegeneration, and other disorders. We have recently found its alterations in the brains with Alzheimer's disease, which might provide important clues to the mechanisms of some unique pathologies. To provide better understanding of this promising molecule, we here summarize research progresses in genetics, pathology, biochemistry, cell biology and other studies of Netrin-1 about its mechanistic roles and biomarker potentials with an emphasis on clinical neurodegenerative disorders in order to expand understanding of this promising molecular player in human diseases.
Netrin-1最初被发现是一种用于轴突导向的神经元生长线索,后来其功能在炎症、肿瘤发生、神经退行性变和其他疾病中被确定。我们最近在患有阿尔茨海默病的大脑中发现了它的变化,这可能为一些独特病理机制提供重要线索。为了更好地理解这种有前景的分子,我们在此总结了Netrin-1在遗传学、病理学、生物化学、细胞生物学和其他研究方面的进展,涉及它的作用机制和作为生物标志物的潜力,重点是临床神经退行性疾病,以扩展对这种在人类疾病中具有前景的分子参与者的理解。